CRP and cardiovascular disorder: Despite a few notable exceptions such as MammaPrint, the successful discovery of molecular signatures has largely been hampered by limited reproducibility and variable performance on independent test sets [22–28], as well as difficulty in identifying signatures that outperform standard clinical measurements like the cardiovascular disease risk C-reactive protein (CRP) [29].